As low-ADRB2 tumors are unable to undergo ADT-induced neuroendocrine differentiation, low-ADRB2 tumors represent a model for androgen-driven CRPC adenocarcinoma [125]. The gene discussed is ADRB2; the disease is adenocarcinoma.